Product Information
IBANDRONATE SODIUM 150 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $2.8096 per EA under NDC 65862023703. Its NADAC has been published 494 times since Jan 11, 2017.
Strength
150 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862023703
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IBANDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA204502On Market Since
3/11/2016
Pharmacological Classes
Price Statistics
The NADAC for IBANDRONATE SODIUM 150 MG TAB has been published 494 times since Jan 11, 2017, and over the history we have for it it has declined 82.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8096 per EA |
|---|---|
| All-time high | $15.6377 (Jan 11, 2017) |
| All-time low | $2.7262 (Nov 20, 2024) |
| 52-week high | $3.5001 |
| 52-week low | $2.7879 |
| Median price | $5.5934 |
| Average price | $5.9137 |
| Largest weekly change | -37.5% (Nov 20, 2024) |
| Weeks tracked | 494 |
| Tracking since | Jan 11, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Ibandronate Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of IBANDRONATE SODIUM 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IBANDRONATE SODIUM 150 MG TAB, manufactured by Aurobindo Pharma Limited, is $2.8096 per EA (NDC 65862023703), effective Jun 24, 2026.
How has the price of IBANDRONATE SODIUM 150 MG TAB changed over time?
Over the history we have for it, the NADAC for IBANDRONATE SODIUM 150 MG TAB has declined 82.0%. It has been tracked across 494 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for IBANDRONATE SODIUM 150 MG TAB?
Since Jan 11, 2017, the NADAC for IBANDRONATE SODIUM 150 MG TAB has ranged from a low of $2.7262 (Nov 20, 2024) to a high of $15.6377 (Jan 11, 2017), with a median of $5.5934 per EA.
Are there cheaper alternatives to IBANDRONATE SODIUM 150 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of IBANDRONATE SODIUM 150 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures IBANDRONATE SODIUM 150 MG TAB?
IBANDRONATE SODIUM 150 MG TAB (NDC 65862023703) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification